van den Berg Hendrik, Kroon Herman M, Slaar Annelie, Hogendoorn Pancras
Department of Pediatric Oncology, Emma Children Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
J Pediatr Orthop. 2008 Jan-Feb;28(1):29-35. doi: 10.1097/BPO.0b013e3181558cb5.
Data on childhood bone tumors are mainly confined to reports on malignant tumors or on institutional registries. Incidence figures on both benign and malignant bone tumors in childhood are lacking.
From January 1999 to December 2003, 1474 newly diagnosed bone tumors in children up to 18 years were registered in Pathologisch Anatomisch Landelijk Geautomatiseerd Archief (the nationwide network and registry of histopathology and cytopathology in The Netherlands). Data provided were diagnosis, date of birth, age at diagnosis, and localization. For incidence calculations, data on age and sex in each year of investigation were obtained from the StatLine database of Statistics Netherlands (www.cbs.nl).
RESULTS/CONCLUSIONS: Incidence of pathology-proven bone tumors in children is low. Incidence of pathology-proven bone tumors in The Netherlands is 79.3 per 1,000,000. From the very first year of life, incidence increases from 3.9 per 1,000,000 to a peak at 13 to 15 years of 142.9 per 1,000,000. Osteochondromas are the most prevalent tumors, followed by aneurysmal bone cysts. The overall incidence is higher for male compared with female patients, mainly due to different frequencies found in aneurysmal bone cysts, Ewing sarcoma, and osteochondroma. Shifts in incidence differ among the various tumors. In infants, bone tumors are mainly chondromas and fibrous dysplasia, which both show a steady increase at older ages. Tumors most prevalent at older ages are osteochondromas, osteosarcomas, osteoid osteomas, and chondromas. A peak incidence at approximately the age of 10 is noted for solitary bone cysts, nonossifying fibromas, and osteoblastomas. Small children more often have localizations in the skull and facial bones. Comparison with literature data showed significant differences due to referral-based institutionally bias, whereas tumor registries only give data for specific tumor types.
关于儿童骨肿瘤的数据主要局限于恶性肿瘤报告或机构登记。缺乏儿童良性和恶性骨肿瘤的发病率数据。
1999年1月至2003年12月,荷兰病理解剖全国自动化存档系统(荷兰组织病理学和细胞病理学的全国性网络及登记处)登记了1474例18岁及以下儿童新诊断的骨肿瘤。提供的数据包括诊断、出生日期、诊断时年龄和肿瘤部位。为了计算发病率,从荷兰统计局的StatLine数据库(www.cbs.nl)获取各调查年份的年龄和性别数据。
结果/结论:经病理证实的儿童骨肿瘤发病率较低。荷兰经病理证实的骨肿瘤发病率为每100万人79.3例。从出生第一年起,发病率从每100万人3.9例增加到13至15岁时的峰值每100万人142.9例。骨软骨瘤是最常见的肿瘤,其次是骨动脉瘤样囊肿。男性患者的总体发病率高于女性,主要是由于骨动脉瘤样囊肿、尤因肉瘤和骨软骨瘤的发病频率不同。不同肿瘤的发病率变化有所不同。在婴儿中,骨肿瘤主要是软骨瘤和纤维发育不良,这两种肿瘤在年龄较大时均呈稳步上升趋势。年龄较大时最常见的肿瘤是骨软骨瘤、骨肉瘤、骨样骨瘤和软骨瘤。孤立性骨囊肿、非骨化性纤维瘤和成骨细胞瘤在大约10岁时发病率达到峰值。幼儿的肿瘤更常发生在颅骨和面部骨骼。与文献数据比较显示,由于基于转诊的机构性偏差存在显著差异,而肿瘤登记仅提供特定肿瘤类型的数据。